Alumni. Game-changing malaria research.
The World Health Organization reports that malaria afflicts 212 million people globally and kills nearly 429,000 every year. With spreading resistance to the drugs and insecticides that help treat and prevent malaria in areas of high transmission, the development of novel tools to interrupt malaria’s diffusion is desperately needed. That’s where the work of Bloomberg School graduates like Andrew Pike, PhD ’15, comes in.
Working alongside some of the most influential experts in malaria research, Andrew’s interest focuses on the development of genetically modified mosquitoes that are unable to spread malaria, permanently stopping transmission in the areas where they are deployed. While these mosquitoes are not yet ready for release, they represent hope for a future where antimalarial drugs and insecticides are not needed to control the disease.
Novel ideas, lifesaving solutions and game-changing research are part of the DNA of Bloomberg School students.